Umemoto, Seiji
Article History
First Online: 27 November 2014
Competing interests
: SU received consultant fee from Boehringer Ingelheim Japan, honoraria from Kyowa Hakko Kirin, Takeda Pharmaceutical, Mochida Pharmaceutical, Eisai and Asuka Pharmaceutical and grant from Maruha Nichiro Holdings.